Dopamine receptor mechanism(s) and morphine tolerance in mice

Based on our previous demonstration of the involvement of dopamine-2 (D-2) dopamine receptors in morphine antinociception, we examined the role of D-2 dopamine receptors in the expression and development of tolerance to morphine antinociception in mice. Tolerance to morphine antinociception was assessed by the tail-flick response after the administration of morphine (50 mg/kg) once daily for 3 days. The D-2 dopamine receptor agonist, quinpirole (0.01, 0.02 and 0.03 mg/kg), but not the D-2 dopamine receptor antagonist, sulpiride (12.5, 25 and 50 mg/kg), increased morphine antinociception in morphine non pre-exposed mice. The response of quinpirole was decreased by the lower doses of sulpiride. Both quinpirole and sulpiride decreased the expression and development of tolerance to antinociception induced by morphine (1.5, 3 and 6 mg/kg). The effect of quinpirole on the expression and development of tolerance, was reduced by a lower and per se non-effective dose of sulpiride. It was concluded that D-2 dopaminergic receptors may play a part in the expression and development of tolerance to the antinociceptive effect of morphine.